Ezetimibe/rosuvastatin

Ezetimibe/rosuvastatin, sold under the brand name Ridutrin among others, is a combination medication used to treat high cholesterol. In some countries it is sold as a kit or a pack containing two distinct pills.
The combination was approved for medical use in the United States in March 2021.

Medical uses

Ezetimibe/rosuvastatin is indicated as an adjunct to diet in people with primary non-familial hyperlipidemia to reduce low-density lipoprotein cholesterol ; and alone or as an adjunct to other LDL-C-lowering therapies in people with homozygous familial hypercholesterolemia to reduce LDL-C.

Pharmacology

Ezetimibe/rosuvastatin combines two lipid-lowering therapies.

Ezetimibe inhibits NPC1L1, the transporter that is responsible for absorption of dietary cholesterol from the intestine.
Rosuvastatin inhibits HMG-CoA reductase, an enzyme involved in synthesis of new cholesterol in the liver.